Showing results (191-200 of 351) with videos related to

Sort By:
Pageof 36
Hepatology International|March 20, 2022
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver diseaseNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2010
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapyTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology|April 17, 2013
Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1Norio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Journal of Clinical Microbiology|November 8, 2013
Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infectionNorio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2007
Prolonged hepatitis after acute infection with genotype H hepatitis B virusNorio Chihara, Yasuji Arase, Fumitaka Suzuki, et al.
Virology Journal|December 25, 2015
Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infectionKeiichi Masaki, Fumitaka Suzuki, Tasuku Hara, et al.
Hepatology Communications|February 7, 2018
Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsiesNorio Akuta, Chizuru Watanabe, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 21, 2018
Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1bYasue Takeuchi, Norio Akuta, Hitomi Sezaki, et al.
Journal of Medical Virology|February 19, 2010
Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirinNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Internal Medicine (Tokyo, Japan)|June 4, 2010
Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus loadYasuji Arase, Fumitaka Suzuki, Norio Akuta, et al.
Pageof 36